Takeda Pharmaceutical (4502.TSE) Q1 2025 Earnings

30JanConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-2
19
40
62

Details

Expected EPS
26
Actual EPS
15
Surprise EPS
-11
Surprise Percent
+42.17%

Description

Takeda Pharmaceutical (4502.TSE) has reported earnings of 15 per share for Q1 2025.

0 Comments

Share your thoughts